Biomarin Pharmaceutical Inc. - Registered Shares

NASDAQ:BMRN   12:35:40 PM EDT
78.34
+0.58 (+0.75%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)14.36B
Current PE17.16
Forward PE N/A
2yr Forward PE 105.86
See more stats
Estimates Current Quarter
Revenue$436.56 Million
Adjusted EPS-$0.24
See more estimates
10-Day MA$78.22
50-Day MA$78.44
200-Day MA$80.45
See more pivots

Biomarin Pharmaceutical Inc. - Registered Shares Stock, NASDAQ:BMRN

770 Lindaro Street, San Rafael, California 94901
United States of America
Phone: +1.415.506.6700
Number of Employees: 3059

Description

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.